BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38236536)

  • 1. Isolating Primary Tumor Cells from the MMTV-PyMT Mouse Model and Their Use in Developing an Orthotopic Mouse Model of Breast Cancer.
    Kozak A; Vasiljeva O; Mikhaylov G
    Methods Mol Biol; 2024; 2773():59-65. PubMed ID: 38236536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
    Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
    Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
    Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
    Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary Selenium Supplementation Does Not Attenuate Mammary Tumorigenesis-Mediated Bone Loss in Male MMTV-PyMT Mice.
    Yan L; Nielsen FH; Sundaram S; Cao J
    Biol Trace Elem Res; 2020 Mar; 194(1):221-227. PubMed ID: 31187394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.
    Christenson JL; Butterfield KT; Spoelstra NS; Norris JD; Josan JS; Pollock JA; McDonnell DP; Katzenellenbogen BS; Katzenellenbogen JA; Richer JK
    Horm Cancer; 2017 Apr; 8(2):69-77. PubMed ID: 28194662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
    Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
    Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer.
    Lal JC; Townsend MG; Mehta AK; Oliwa M; Miller E; Sotayo A; Cheney E; Mittendorf EA; Letai A; Guerriero JL
    Breast Cancer Res; 2021 Aug; 23(1):83. PubMed ID: 34353349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
    Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE
    Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-2 modulates mammary tumor progression in response to collagen density.
    Esbona K; Inman D; Saha S; Jeffery J; Schedin P; Wilke L; Keely P
    Breast Cancer Res; 2016 Mar; 18(1):35. PubMed ID: 27000374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.
    Nielsen BS; Egeblad M; Rank F; Askautrud HA; Pennington CJ; Pedersen TX; Christensen IJ; Edwards DR; Werb Z; Lund LR
    PLoS One; 2008 Aug; 3(8):e2959. PubMed ID: 18698413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-derived mesenchymal stem cells and orthotopic site increase the tumor initiation potential of putative mouse mammary cancer stem cells derived from MMTV-PyMT mice.
    Lanza DG; Ma J; Guest I; Uk-Lim C; Glinskii A; Glinsky G; Sell S
    Tumour Biol; 2012 Dec; 33(6):1997-2005. PubMed ID: 22836804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyzing the Role of Proteases in Breast Cancer Progression and Metastasis Using Primary Cells from Transgenic Oncomice.
    Vasiljeva O; Sevenich L; Reinheckel T
    Methods Mol Biol; 2021; 2294():275-293. PubMed ID: 33742409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo.
    Attalla S; Taifour T; Bui T; Muller W
    Oncogene; 2021 Jan; 40(3):475-491. PubMed ID: 33235291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.
    Berger T; Cheung CC; Elia AJ; Mak TW
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2995-3000. PubMed ID: 20133630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment regulates metastasis and metastasis genes of mouse MMTV-PymT mammary cancer cells in vivo.
    Werbeck JL; Thudi NK; Martin CK; Premanandan C; Yu L; Ostrowksi MC; Rosol TJ
    Vet Pathol; 2014 Jul; 51(4):868-81. PubMed ID: 24091811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages.
    Boyle ST; Faulkner JW; McColl SR; Kochetkova M
    Mol Cancer; 2015 Jun; 14():115. PubMed ID: 26047945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer Promotes Cardiac Dysfunction Through Deregulation of Cardiomyocyte Ca
    da Costa TSR; Urias U; Negrao MV; Jordão CP; Passos CS; Gomes-Santos IL; Salemi VMC; Camargo AA; Brum PC; Oliveira EM; Hajjar LA; Chammas R; Filho RK; Negrao CE
    J Am Heart Assoc; 2021 Feb; 10(5):e018076. PubMed ID: 33619982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
    Zuo Y; Ulu A; Chang JT; Frost JA
    Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of Cd151 reduces mammary tumorigenesis in the MMTV/PyMT mouse model.
    Roselli S; Kahl RG; Copeland BT; Naylor MJ; Weidenhofer J; Muller WJ; Ashman LK
    BMC Cancer; 2014 Jul; 14():509. PubMed ID: 25012362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammary tumor growth and metastasis are reduced in c-Kit mutant Sash mice.
    He L; Zhu Z; Chen S; Wang Y; Gu H
    Cancer Med; 2016 Jun; 5(6):1292-7. PubMed ID: 26992445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.